Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Endocrinological Investigation
|
March 1, 1996
Microprolactinomas: why requiem for surgery?
A Liuzzi, G Oppizzi
The Journal of Endocrinology
|
December 9, 1997
Evidence for octreotide subcutaneously in the treatment of acromegaly
A Liuzzi, G Oppizzi
European Journal of Endocrinology
|
September 4, 1999
A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly
R Cozzi, D Dallabonzana, R Attanasio, et al.
Minerva Endocrinologica
|
January 1, 1990
[Medical treatment of acromegaly with dopaminergic agents]
A Liuzzi, D Dallabonzana, G Oppizzi, et al.
Journal of Endocrinological Investigation
|
June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growth
A Liuzzi, P G Chiodini, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1985
Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine
P G Chiodini, A Liuzzi, D Dallabonzana, et al.
Pediatric Transplantation
|
May 10, 2002
Lipid profile during rhGH therapy in pediatric renal transplant patients
L Ghio, B Damiani, R Garavaglia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1986
Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly
R Cozzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1980
Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegaly
G Oppizzi, L Botalla, G Verde, et al.
Journal of Endocrinological Investigation
|
April 1, 1985
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas
G Verde, G Oppizzi, P G Chiodini, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Endocrinological Investigation
|
March 1, 1996
Microprolactinomas: why requiem for surgery?
A Liuzzi, G Oppizzi
The Journal of Endocrinology
|
December 9, 1997
Evidence for octreotide subcutaneously in the treatment of acromegaly
A Liuzzi, G Oppizzi
European Journal of Endocrinology
|
September 4, 1999
A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly
R Cozzi, D Dallabonzana, R Attanasio, et al.
Minerva Endocrinologica
|
January 1, 1990
[Medical treatment of acromegaly with dopaminergic agents]
A Liuzzi, D Dallabonzana, G Oppizzi, et al.
Journal of Endocrinological Investigation
|
June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growth
A Liuzzi, P G Chiodini, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1985
Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine
P G Chiodini, A Liuzzi, D Dallabonzana, et al.
Pediatric Transplantation
|
May 10, 2002
Lipid profile during rhGH therapy in pediatric renal transplant patients
L Ghio, B Damiani, R Garavaglia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1986
Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly
R Cozzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1980
Homogeneity in the growth hormone-lowering effect of dopamine and somatostatin in acromegaly
G Oppizzi, L Botalla, G Verde, et al.
Journal of Endocrinological Investigation
|
April 1, 1985
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas
G Verde, G Oppizzi, P G Chiodini, et al.
Page
of 4